Murphy Douglas A, Psarev Sergey, Jonnson Amalia A, Halkos Michael E
Division of Cardiothoracic Surgery, Emory University School of Medicine, Atlanta, GA, USA.
Department of Biomedical Engineering, Emory Saint Joseph's Hospital, Atlanta, GA, USA.
Innovations (Phila). 2024 Sep-Oct;19(5):485-493. doi: 10.1177/15569845241278605. Epub 2024 Sep 20.
Safety and sustainability are key elements of a robotic mitral valve (MV) program at any stage of development. Challenges include the positioning of the surgeon at the robotic console, increasing patient complexity, and upstream administrative staffing difficulties. We instituted a systems approach to maximize patient safety and maintain robotic service viability.
A single dedicated robotic operating room (OR) was equipped as a microsystem with team training in the operative steps, ergonomics, digital tools, and an explicit culture of safety. Outcomes of all robotic mitral procedures including concomitant procedures in the microsystem OR by a single surgeon were retrospectively reviewed.
From January 2014 through December 2023, 1,529 consecutive MV patients were operated with an endoscopic robotic approach. Ten patients (0.65%) were converted to conventional approaches. Overall, 1,300 MV repairs (85%) were performed with residual MV regurgitation of none to trace in 1,205 patients (92.7%), mild in 92 patients (7.1%), and moderate in 3 patients (0.23%). MV replacements were performed in 229 patients (15%) with no paravalvular leaks. Mortality was 0.08% in the repair group and 0.87% in the replacement group. No deaths have occurred in the last 38 months. Stroke occurred in 0.31% of repair patients and 1.3% of replacement patients. One patient developed transient renal failure.
Organization of the robotic OR as a microsystem is associated with surgical efficacy and very low morbidity and mortality. A comparable microsystem approach using all or select components may promote safety and sustainability for robotic MV programs at all levels.
在机器人二尖瓣(MV)项目的任何发展阶段,安全性和可持续性都是关键要素。挑战包括外科医生在机器人控制台的定位、患者复杂性增加以及上游行政人员配备困难。我们采用了一种系统方法来最大限度地提高患者安全性并维持机器人服务的可行性。
一个专门的机器人手术室(OR)被配置为一个微系统,团队在手术步骤、人体工程学、数字工具以及明确的安全文化方面接受培训。对所有机器人二尖瓣手术的结果进行回顾性分析,包括由单一外科医生在该微系统手术室进行的同期手术。
从2014年1月至2023年12月,连续1529例MV患者接受了内镜机器人手术。10例患者(0.65%)转为传统手术方式。总体而言,共进行了1300例MV修复手术(85%),1205例患者(92.7%)术后二尖瓣反流无至微量,92例患者(7.1%)为轻度,3例患者(0.23%)为中度。229例患者(15%)进行了二尖瓣置换,无瓣周漏。修复组死亡率为0.08%,置换组为0.87%。在过去38个月中未发生死亡病例。修复患者中风发生率为0.31%,置换患者为1.3%。1例患者出现短暂性肾衰竭。
将机器人手术室组织为一个微系统与手术疗效以及极低的发病率和死亡率相关。使用全部或部分组件的类似微系统方法可能会在各个层面促进机器人MV项目的安全性和可持续性。